Abstract
Several different classes of compounds enhance the potency of aminergic receptor ligands three-fold or more and increase their duration of activity up to ten-fold. These enhancers include the vitamins ascorbic acid and folic acid, chelators such as ethylenediaminetetraacetic acid, corticosteroids, and opioids, opiates and opiate antagonists. We have previously demonstrated that all of these classes of enhancers share a common molecular motif consisting of a linear array of two hydroxyls and a carbonyl. We demonstrate here that because of this common molecular motif, all compounds known to enhance aminergic receptor ligands bind to highly conserved regions of the first or second extracellular loops of aminergic receptors at physiologically or pharmacologically relevant concentrations. These compounds also bind directly to aminergic ligands with significant specificity and affinity. These results suggest three very simple, complementary methods for screening for novel extracellular aminergic receptor enhancers: 1) in silico screening for the presence of the common aminergic receptor enhancer motif; 2) screening for binding to the aminergic ligand of choice; and 3) screening for binding to receptor peptides representing the enhancer binding site on the receptor. Using these three complementary methods, we predict a new class of enhancers (tartaric acids) and demonstrate the predicted enhancement in an in vitro smooth muscle assay.
Keywords: Ascorbate, enhancers, epinephrine, fade, norepinephrine, tachyphylaxis, tartrate.
Current Drug Discovery Technologies
Title:Tartaric Acid Enhances Adrenergic Receptor Activity: Test of a General Theory of Extracellular Aminergic GPCR Enhancer Discovery
Volume: 11 Issue: 4
Author(s): Robert Root-Bernstein, Jenna Fewins and Patrick F. Dillon
Affiliation:
Keywords: Ascorbate, enhancers, epinephrine, fade, norepinephrine, tachyphylaxis, tartrate.
Abstract: Several different classes of compounds enhance the potency of aminergic receptor ligands three-fold or more and increase their duration of activity up to ten-fold. These enhancers include the vitamins ascorbic acid and folic acid, chelators such as ethylenediaminetetraacetic acid, corticosteroids, and opioids, opiates and opiate antagonists. We have previously demonstrated that all of these classes of enhancers share a common molecular motif consisting of a linear array of two hydroxyls and a carbonyl. We demonstrate here that because of this common molecular motif, all compounds known to enhance aminergic receptor ligands bind to highly conserved regions of the first or second extracellular loops of aminergic receptors at physiologically or pharmacologically relevant concentrations. These compounds also bind directly to aminergic ligands with significant specificity and affinity. These results suggest three very simple, complementary methods for screening for novel extracellular aminergic receptor enhancers: 1) in silico screening for the presence of the common aminergic receptor enhancer motif; 2) screening for binding to the aminergic ligand of choice; and 3) screening for binding to receptor peptides representing the enhancer binding site on the receptor. Using these three complementary methods, we predict a new class of enhancers (tartaric acids) and demonstrate the predicted enhancement in an in vitro smooth muscle assay.
Export Options
About this article
Cite this article as:
Root-Bernstein Robert, Fewins Jenna and F. Dillon Patrick, Tartaric Acid Enhances Adrenergic Receptor Activity: Test of a General Theory of Extracellular Aminergic GPCR Enhancer Discovery, Current Drug Discovery Technologies 2014; 11 (4) . https://dx.doi.org/10.2174/157016381104150507121846
DOI https://dx.doi.org/10.2174/157016381104150507121846 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Call for Papers in Thematic Issues
Advancements in Computational Methods for Drug Design
This thematic issue delves into the cutting-edge computational methodologies revolutionizing drug design. Emphasizing the integration of in silico techniques, this collection highlights advancements in some computational methods, as: molecular docking, molecular dynamics, QSAR (Quantitative Structure-Activity Relationship) and free energy calculations. These approaches enhance the efficiency of drug discovery, reduce costs, ...read more
Disease Modelling: Emerging Frontiers in Disease Modelling: Data to Drug Discovery in Bioinformatics in Precision Medicine and Health Science
The special issue on "Emerging Frontiers in Disease Modelling: Data to Drug Discovery in Bioinformatics in Precision Medicine and Health Science" aims to explore the transformative role of bioinformatics in bridging the gap between extensive biological data and the development of targeted therapies. This issue will highlight cutting-edge research and ...read more
Novel drug delivery therapeutics: Opportunities and challenges for combating diseases
The field of drug delivery therapeutics has undergone significant transformation with the emergence of innovative technologies designed to enhance therapeutic efficacy and patient outcomes. As traditional drug administration methods encounter limitations in terms of efficacy, safety, and patient compliance, novel drug delivery systems offer promising solutions to these challenges. Advancements ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
Current Cancer Therapy Reviews Evaluation of the Effect of Nimodipine o.d. (Extended Release) vs Nimodipine t.i.d. in the Treatment of Peripheral Vertigo
Current Drug Delivery Meet Our Editor:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke
Current Medicinal Chemistry Serum Creatinine vs. Albuminuria as Biomarkers for the Estimation of Cardiovascular Risk
Current Vascular Pharmacology Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism Cu(II) Schiff Base as Catalyst in the Synthesis of 1,8-Dioxodecahydroacridine
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic: Tocotrienols: Potential Drug Targets for Cardiovascular, Cancer and Neurological Diseases (Executive Guest Editor: Dipak K. Das)]
Current Pharmaceutical Design Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Life-Threatening Respiratory Syncytial Virus Disease in Children
Current Respiratory Medicine Reviews Transcending the Cutaneous Barrier Through Nanocarrier Exploration for Passive Delivery of Anti-hypertensive Drugs: A Critical Review
Recent Patents on Nanotechnology Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Pro Atrial Natriuretic Peptide (1-30) and 6-keto PGF<sub>1α</sub> Activity Affects Na<sup>+</sup> Homeostasis in Non-modulating Hypertension
Current Hypertension Reviews Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Editorial (Thematic Issue: Interventional Management of Hypertension and Cardiovascular Disease: The Beginning of a New Era?)
Current Vascular Pharmacology Pharmacological Management of Hypertension in the Elderly - Certitudes and Controversies
Current Pharmaceutical Design Effects of N-acetylcysteine on Pulmonary Functions in Patients with Systemic Sclerosis: A Randomized Double Blind, Placebo Controlled Study
Current Rheumatology Reviews Improved Methods of Extraction and In Vitro Evaluation of Antimicrobial Potential of Stem Bark of Terminalia arjuna
Current Biochemical Engineering (Discontinued)